Skip to main content
2024 CRT Conference Main banner
Back

Megan Coylewright, MD, MPH

Vice Chief of Cardiology and Director of Structural Heart Program
The Erlanger Heart and Lung Institute
Chattanooga, Tennessee, United States

Dr. Coylewright is a research scientist, mentor, and clinical leader in interventional cardiology, and Director of the Structural Heart Program for Erlanger Health System in Chattanooga, TN. As a clinical trialist, she serves as national PI for the interatrial shunt trial, FROST-HF, and is a leader for the moderate aortic stenosis trial, EXPAND TAVR II, as well as additional trials of left atrial appendage closure and transcatheter mitral interventions. As a committed teacher and international speaker, Dr. Coylewright has a clear passion for innovative health care delivery models that place patients at the center: many of her publications focus on shared decision making implementation. Her research also includes a focus on diversity, equity and inclusion, complimenting her role as Vice Chief of Cardiology for Faculty Development within southern Tennessee's only academic cardiovascular program.

Disclosure information not submitted.

Presentation(s):